Suppression of circadian secretion of glucagon-like peptide-1 by the saturated fatty acid, palmitate

被引:36
|
作者
Martchenko, A. [1 ]
Oh, R. H. [1 ]
Wheeler, S. E. [1 ]
Gurges, P. [1 ]
Chalmers, J. A. [1 ]
Brubaker, P. L. [1 ,2 ]
机构
[1] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
Bmal1; exocytosis; GLP-1; mitochondrial metabolism; Nampt; DIET-INDUCED OBESITY; INSULIN-SECRETION; GENE-EXPRESSION; CLOCK GENES; METABOLISM; RHYTHMS; STRESS; CYCLE; BMAL1; GLP-1;
D O I
10.1111/apha.13007
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
AimGlucagon-like peptide-1 is an incretin hormone secreted by the intestinal L-cell with a circadian rhythm that parallels expression of the core clock gene, Bmal1. Although feeding rats a high-fat/high-sucrose Western diet impairs rhythmic glucagon-like peptide-1 release, the mechanisms underlying this effect remain unclear. Therefore, the aim of this study was to determine the pathway(s) by which the saturated fat, palmitate, a major component of the Western diet, impairs circadian glucagon-like peptide-1 secretion. MethodsMurine mGLUTag L-cells were synchronized, and the effects of palmitate pre-treatment on gene expression and glucagon-like peptide-1 secretion were determined, in addition to metabolite quantification, mitochondrial function analysis and enzyme inhibition and activation assays. Glucagon-like peptide-1 secretion was also analysed in ileal crypt cultures from control and Bmal1 knockout mice. ResultsPre-treatment with palmitate dampened Bmal1 mRNA and protein expression and glucagon-like peptide-1 secretion at 8 but not 20 hours after cell synchronization (P < .05-.001). Glucagon-like peptide-1 release was also impaired in Bmal1 knockout cultures as compared to wild-type controls (P < .001). Palmitate pre-treatment reduced expression of the Bmal1 downstream target, nicotinamide phosphoribosyltransferase, the rate-limiting enzyme in the synthesis of NAD(+). This was paralleled by dampening of total NAD(+) levels, as well as impaired mitochondrial function and ATP production (P < .05-.001). Whereas direct inhibition of nicotinamide phosphoribosyltransferase also decreased glucagon-like peptide-1 release, activation of this enzyme restored glucagon-like peptide-1 secretion in the presence of palmitate. ConclusionPalmitate impairs L-cell clock function at the peak of Bmal1 gene expression, thereby impairing mitochondrial function and ultimately rhythmic glucagon-like peptide-1 secretion.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Palmitate Disrupts Circadian Synthesis and Secretion of Glucagon-like Peptide-1 from the Intestinal L Cell
    Martchenko, Alexandre
    Oh, Hyun Seo Robin
    Brubaker, Patricia L.
    DIABETES, 2016, 65 : A488 - A489
  • [2] EFFECT OF GLUCAGON ON SECRETION OF GLUCAGON-LIKE PEPTIDE-1
    SHIMA, K
    OHBOSHI, C
    SATO, M
    HIROTA, M
    HORMONE AND METABOLIC RESEARCH, 1988, 20 (02) : 123 - 124
  • [3] Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid
    Fernandes, Maria F.
    Tomczewski, Michelle, V
    Duncan, Robin E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [4] Circadian Variations in Glucagon-Like Peptide-1 Responses
    Gil-Lozano, Manuel
    Mingomataj, Erli
    Brubaker, Patricia L.
    DIABETES, 2012, 61 : A478 - A478
  • [5] Glucagon-like peptide-1 and control of insulin secretion
    Thorens, B
    DIABETES & METABOLISM, 1995, 21 (05) : 311 - 318
  • [6] Glucagon-like peptide-1 secretion in bulimia nervosa
    Brambilla, Francesca
    Monteleone, Palmiero
    Maj, Mario
    PSYCHIATRY RESEARCH, 2009, 169 (01) : 82 - 85
  • [7] Nutritional regulation of glucagon-like peptide-1 secretion
    Tolhurst, Gwen
    Reimann, Frank
    Gribble, Fiona M.
    JOURNAL OF PHYSIOLOGY-LONDON, 2009, 587 (01): : 27 - 32
  • [8] Multi-action Secretagogin Controls Circadian Glucagon-Like Peptide-1 Secretion
    Sen, Satish
    Javeed, Naureen
    ENDOCRINOLOGY, 2022, 163 (12)
  • [9] Glucagon and glucagon-like peptide-1
    Livingston, JN
    Schoen, WR
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 189 - 198
  • [10] Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo
    Yabe, Daisuke
    Rokutan, Mariyo
    Miura, Yoshiyuki
    Komoto, Izumi
    Usui, Ryota
    Kuwata, Hitoshi
    Watanabe, Koin
    Hyo, Takanori
    Kurose, Takeshi
    Nagamatsu, Terumi
    Shimizu, Shinobu
    Kawai, Jun
    Imamura, Masayuki
    Seino, Yutaka
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 102 (01) : E1 - E4